INDIVIOR PLC DL 0,50/ GB00BN4HT335 /
22/06/2024 13:03:41 | Chg. 0.000 | Volume | Bid13:03:41 | Ask13:03:41 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
15.700EUR | 0.00% | - Turnover: - |
15.700Bid Size: - | 15.900Ask Size: - | 2.13 bill.EUR | - | - |
GlobeNewswire
06/06
Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update
GlobeNewswire
31/05
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
18/04
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire
11/04
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18,...
GlobeNewswire
03/04
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Mod...
GlobeNewswire
05/03
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire
31/01
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
GlobeNewswire
23/11/2023
Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on Novem...
Newsfile Corp
31/10/2023
Pharma and Biotech Business Development Leaders to Discuss Psychedelics Partnering at Wonderland